|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 01, 2018 ) According to Data Bridge Market Research new Market report, Global Digital Pathology Market By Product (Scanners, Software, Communication Systems, Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education), By End Users (Pharmaceutical & Biotechnology Companies, Hospital and Reference Laboratories and Academic & Research Institutes), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Industry Trends and Forecast is projected to reach USD 1,099.30 million by 2025, at a CAGR of 12.4% during the forecast period of 2018 to 2025.
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-pathology-market/
Global Digital Pathology Market
Digital pathology is the use of computer technology to convert analog microscopic images into digital images. The rise in new cancer cases and shortage of pathologists are the key factors for the increasing demand of digital pathology solutions. Digital pathology solutions are best for the diagnosis of oncology cases. According to, WHO, in 2017 the number of new cases of cancer are expected to rise by about 70% over the next two decades.
Technological advancements such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are some of the key factors contributing toward the rising adoption of digital pathology. In addition, introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve this industry as a potential growth driver.
In April 2017, Royal Philips launched IntelliSite Pathology Solution. This is the first digital pathology product to receive FDA approval for primary diagnostics purpose. In April 2017, Philips Medical Systems received the FDA approval in the field of digital pathology to market its whole slide imaging (WSI) system for primary diagnosis for clinical use. In Digital pathology market companies are taking new product development activities, collaborations, mergers and acquisitions to expand product portfolio to changing customer demands. In March 2017, Leica Biosystems entered into a strategic partnership with Leeds Hospital to improve productivity and image analytics. In June 2016, Royal Philips, acquired PathXL, one of the largest pathology, image-based analysis firms.
Market Segmentation: Global Digital Pathology Market
The Global Market for Digital Pathology by the following sub-categories is presented
By Product
o Scanners
o Software
o Communication Systems
o Storage Systems
By Type
o Human Pathology
o Veterinary Pathology
By Application
o Teleconsultation
o Disease Diagnosis
o Drug Discovery
o Training & Education
By End User
o Pharmaceutical & Biotechnology Companies
o Hospital and Reference Laboratories
o Academic & Research Institutes
By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digital-pathology-market
FACTORS DRIVING GROWTH IN THE GLOBAL DIGITAL PATHOLOGY MARKET
Rising demand for accurate & faster diagnosis:
According to WHO, cancer is one of the leading causes of deaths worldwide and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. Digital pathology is helpful in providing accurate & faster detection and diagnosis of chronic diseases. It detects tumor at inflammatory and proliferating cells stage. It also reduces cost by eliminating the requirement of FISH tests and impacts the laboratory workflow positively. Digital Pathology is very efficient in cancer research and clinical practice due to the availability of whole slide scanners for complete pathology slide digitalization, and the development of several computational methods for histopathology image analysis. Hence this has increased the market of digital pathology market.
Growing focus of market players
The global digital pathology market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. The report also covers the market shares for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America bleeding disorder treatment market.
Some of the major players operating in global absorbable and non-absorbable sutures are,
Ventana Medical Systems, Inc.,
Definiens,
Omnyx,
LLC,Hamamatsu Photonics K.K.Corista,General Electric Company,
Koninklijke Philips N.V.,
Inspirata,
3DHISTECH,
Olympus Corporation,
Sectra AB,
PerkinElmer Inc.,
Leica Biosystems Nussloch GmbH,
ZEISS International,Apollo Enterprise Imaging Corp,
Mikroscan Technologies, Inc.,
Pixcelldata Ltd.,
VMscope GmbH,
Huron Digital Pathology Inc.,
Objective Pathology Services,
OptraSCAN, Inc.,
Pathcore Inc.,
Agfa-Gevaert Group,Proscia Inc,
Sunquest Information Systems, Inc.,
Indica Labs, Inc,
Inspirata ,,among others.
Access Full Report: https://databridgemarketresearch.com/reports/global-digital-pathology-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Data Bridge Market Research
Data Bridge Market Research
+1-888-387-2818
sopan.gedam@databridgemarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
